Both drugs have potential side effects, including nausea, vomiting, diarrhea, and constipation
FDA Proposes Permanent Ban on Compounded Semaglutide and Tirzepatide On April 30, 2026, the FDA proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, effectively ending large-scale compounding of GLP-1 drugs
Because of this, Ozempic has become one of the most commonly prescribed drugs in the country, with nearly 5 million prescriptions in 2020
Please try accessing it with an alternate browser
Some patients may reach their weight loss goals within a few months, while others may need to stay on weight loss injections for a longer period of time
The best part is you dont need to commit to a super-intense, five-day workout routine in the weight room